|
End-of-day quote
Shanghai S.E.
2026-08-24
|
5-day change | 1st Jan Change | ||
| 14.82 CNY | -1.00% |
|
-3.33% | -1.66% |
| 08-24 | Tasly Pharmaceutical to Buy 4 Billion Yuan of Wealth Management Products | MT |
| 08-24 | Tasly Pharmaceutical's Subsidiary Secures Nod to Trial TSL2402 Tablets | MT |
| Market Cap | 22.14B 3.29B 2.82B 2.64B 2.41B 4.56B 315B 4.6B 31.24B 12.15B 158B 12.37B 12.1B 524B | P/E 2026 * |
16.4x | P/E 2027 * | 13.7x |
|---|---|---|---|---|---|
| Enterprise Value | 20.6B 3.06B 2.63B 2.46B 2.25B 4.24B 293B 4.28B 29.06B 11.3B 147B 11.5B 11.25B 487B | EV / Sales 2026 * |
2.37x | EV / Sales 2027 * | 1.72x |
| Free-Float |
47.15% | Yield 2026 * |
2.79% | Yield 2027 * | 3.48% |
| 1 day | -1.00% | ||
| 1 week | -3.33% | ||
| Current month | -8.06% | ||
| 1 month | -7.08% | ||
| 3 months | +4.44% | ||
| 6 months | +1.02% | ||
| Current year | -1.66% |
| 1 week | 14.68 |  | 15.61 |
| 1 month | 14.68 | | 16.22 |
| Current year | 12.9 | | 16.24 |
| 1 year | 12.9 | | 17.33 |
| 3 years | 12.24 | | 18 |
| 5 years | 9.2 | | 18 |
| 10 years | 9.2 | | 34.22 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jin Yong Cai
CEO | Chief Executive Officer | 54 | 2024-05-07 |
Jie Wei
DFI | Director of Finance/CFO | 49 | 2018-07-08 |
Xin Yang
CIO | Chief Investment Officer | 45 | 2025-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Ai Jian Wang
BRD | Director/Board Member | 72 | 2021-06-01 |
Jin Yong Cai
CHM | Chairman | 54 | 2026-08-09 |
Ke Xin Li
BRD | Director/Board Member | 58 | 2024-05-07 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.00% | -3.33% | -13.18% | +12.27% | 3.33B | |
| +0.34% | -1.06% | -14.12% | -5.48% | 13.09B | |
| +0.04% | -2.86% | -35.89% | -58.06% | 4.85B | |
| -0.72% | -7.55% | -7.99% | -6.69% | 4.59B | |
| -3.71% | -6.60% | -2.46% | -29.63% | 4.09B | |
| +1.05% | -1.24% | -23.25% | +3.48% | 3.51B | |
| +0.04% | -0.45% | -11.34% | -6.44% | 3.34B | |
| -2.19% | -4.59% | -19.98% | -16.50% | 2.43B | |
| -0.65% | -4.13% | -30.80% | -13.84% | 1.67B | |
| +0.20% | -0.61% | -18.82% | +24.24% | 1.65B | |
| Average | -0.66% | -2.42% | -17.78% | -9.67% | 4.26B | |
| Weighted average by Cap. | -0.46% | -2.03% | -16.45% | -11.68% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 8.67B 1.29B 1.11B 1.03B 946M 1.78B 124B 1.8B 12.24B 4.76B 62.04B 4.84B 4.74B 205B | 9.56B 1.42B 1.22B 1.14B 1.04B 1.97B 136B 1.99B 13.48B 5.24B 68.34B 5.34B 5.22B 226B |
| Net income | 1.37B 204M 175M 164M 150M 283M 19.56B 286M 1.94B 754M 9.82B 767M 750M 32.5B | 1.62B 240M 206M 193M 176M 332M 23.02B 336M 2.28B 887M 11.56B 903M 883M 38.24B |
| Net Debt | -1.54B -230M -197M -184M -168M -318M -21.99B -321M -2.18B -847M -11.04B -862M -844M -36.53B | -5.71B -850M -728M -681M -623M -1.18B -81.36B -1.19B -8.06B -3.13B -40.85B -3.19B -3.12B -135B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-24 | CN¥14.82 | -1.00% | 17,084,748 |
| 26-08-21 | CN¥14.97 | -3.23% | 20,310,094 |
| 26-08-20 | CN¥15.47 | +1.51% | 20,380,278 |
| 26-08-19 | CN¥15.24 | -0.97% | 13,280,161 |
| 26-08-18 | CN¥15.39 | +0.20% | 15,488,829 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 600535 Stock
Select your edition
All financial news and data tailored to specific country editions
